Read about breakthrough science, the everyday people who make it happen, and the patients we serve.
Investigational next-generation selective estrogen receptor degraders (SERDs) are a class of small molecules that may exert a big effect on a key driver of breast cancer.
A second-generation Genentech employee, Traci Scovel shares the power of storytelling and spirit in working to help patients who have cancer.
Social media has changed the way that people talk about their health. But given the regulations, how can industry join the conversation?
Tell us what you think about our company, products, or website.
The true sign of intelligence is not knowledge but imagination.